marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Protagonist Therapeutics Financial Statements 2011-2024 | PTGX
Annual Financial Statements Protagonist Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.68 B | 1.18 B | 1.36 B | 712 M | 190 M | 181 M | 389 M | 122 M | - | - | - | - | - |
Shares |
56.8 M | 49 M | 46.3 M | 34.4 M | 25.9 M | 22.4 M | 17.7 M | 6.5 M | - | - | - | - | - |
Historical Prices |
29.6 | 24.1 | 29.3 | 20.7 | 7.55 | 8.15 | 22.9 | 18 | - | - | - | - | - |
Net Income |
-79 M | -127 M | -126 M | -66.2 M | -77.2 M | -38.9 M | -37 M | -37.2 M | -14.9 M | -11.1 M | - | - | - |
Revenue |
60 M | 26.6 M | 27.4 M | 28.6 M | 231 K | 30.9 M | 20.1 M | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-93.7 M | -131 M | -126 M | -64.5 M | -80.5 M | -42.3 M | -37.9 M | -32.7 M | -14.8 M | -9.32 M | - | - | - |
Interest Expense |
-201 K | -80 K | -149 K | 598 K | 169 K | -20 K | -8 K | -34 K | - | - | - | - | - |
EBITDA |
-92.7 M | -130 M | -125 M | -63.6 M | -78 M | -41.7 M | -37.5 M | -32.3 M | -14.5 M | -7.29 M | - | - | - |
Operating Expenses |
154 M | 158 M | 153 M | 93.1 M | 80.8 M | 73.2 M | 58 M | 32.7 M | - | - | - | - | - |
General and Administrative Expenses |
33.5 M | 31.7 M | 27.2 M | 18.6 M | 15.7 M | 13.7 M | 11.8 M | 6.96 M | 2.96 M | 1.86 M | - | - | - |
All numbers in USD currency
Quarterly Income Statement Protagonist Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
61.8 M | 61.3 M | 60.9 M | 57.7 M | 59.2 M | 56.8 M | 50.6 M | 49.3 M | 49.1 M | 49 M | 48.8 M | 47.8 M | 48 M | 44.9 M | 44.2 M | 43.7 M | 37.4 M | 32.8 M | 27.7 M | 27.2 M | 27 M | 24.7 M | 24.3 M | 23.2 M | 22.9 M | 21.2 M | 21.1 M | 21.1 M | 16.9 M | 16.9 M | 16.8 M | 16.7 M | 8.48 M | 384 K | 288 K | 272 K | 272 K | 234 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-33.2 M | -30.6 M | 207 M | - | -34.1 M | -38.5 M | -33.7 M | - | -31.2 M | -41 M | -20.9 M | - | -33.8 M | -30.8 M | -24 M | - | -7.76 M | -19.4 M | -20.1 M | -17.5 M | -16.4 M | -29.2 M | -14.1 M | -13.9 M | -8.74 M | -8.66 M | -7.66 M | -3.05 M | -4.82 M | -15 M | -14.1 M | -11.2 M | -7.08 M | -7.1 M | -11.7 M | -5.49 M | -3.45 M | -3.22 M | -2.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
4.68 M | 4.17 M | 255 M | - | - | - | - | - | 26.6 M | 859 K | 25.7 M | - | 10.3 M | - | 6.19 M | - | 13.1 M | - | - | 2.72 M | 4.14 M | - | 1.56 M | 2.35 M | 6.12 M | 11.7 M | 10.8 M | 11.3 M | 8.78 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-41.5 M | -38.8 M | 206 M | - | -38.3 M | -42.4 M | -36 M | - | -32.3 M | -41.4 M | -21.1 M | - | -33.9 M | -30.9 M | -24 M | - | -7.77 M | -18.2 M | -19.7 M | -17.3 M | -17.2 M | -31.4 M | -14.6 M | -15.4 M | -9.39 M | -9.24 M | -8.23 M | -3.51 M | -4.98 M | -15.1 M | -14.3 M | -11.4 M | -7.14 M | -7.09 M | -7.04 M | -5 M | -4.02 M | -3.08 M | -2.69 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
141 K | 97 K | -19 K | - | -31 K | -19 K | -195 K | - | -86 K | -78 K | 13 K | - | -136 K | -57 K | -79 K | - | 19 K | 209 K | 243 K | - | -106 K | -37 K | -3 K | - | - | - | - | - | - | - | - | - | - | -34 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | 207 M | - | - | - | -35.8 M | - | -31.5 M | -41.4 M | -20.9 M | - | -33.3 M | -30.9 M | -23.8 M | - | -7.17 M | -17.8 M | -19.5 M | -17.3 M | -16.7 M | -31.1 M | -14.5 M | -15.4 M | -8.99 M | -8.99 M | -8.15 M | -3.51 M | -4.69 M | -15 M | -14.2 M | -11.4 M | -6.9 M | -6.93 M | -6.97 M | -5 M | -3.86 M | -2.97 M | -2.69 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
46.1 M | 43 M | 48.6 M | - | 38.3 M | 42.4 M | 36 M | - | 32.3 M | 42.3 M | 46.8 M | - | 44.2 M | 33.1 M | 30.2 M | - | 20.9 M | 24.4 M | 23.3 M | - | 21.3 M | 23.2 M | 16.2 M | - | 15.5 M | 20.9 M | 19 M | - | 13.8 M | 15.1 M | 14.3 M | - | 7.14 M | 7.09 M | 7.04 M | - | 4.02 M | 3.08 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
10.2 M | 9.44 M | 14.9 M | - | 7.66 M | 9.17 M | 8.6 M | - | 6.9 M | 7.69 M | 10.5 M | - | 7.26 M | 6.72 M | 5.96 M | - | 4.89 M | 4.18 M | 4.58 M | - | 4.02 M | 3.86 M | 3.76 M | - | 3.36 M | 3.18 M | 3.64 M | - | 2.59 M | 3.12 M | 2.99 M | - | 1.58 M | 1.4 M | 1.42 M | - | 863 K | 786 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency